{"nct_id":"NCT06952504","title":"A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2025-05-22","start_date_type":"ACTUAL","primary_completion_date":"2032-05-24","primary_completion_date_type":"ESTIMATED","completion_date":"2032-05-24","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}